Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections
Viatris Inc. (VTRS)
Company Research
Source: Business Wire
Collaboration to develop engineered bacteriophage therapeutics targeting bacterial pathogens responsible for serious eye infections RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Locus Biosciences, Inc. (“Locus”), a clinical-stage biotechnology company developing precision engineered bacteriophage treatments for a diverse set of bacterial diseases, today announced a research collaboration agreement with Viatris Inc. (NASDAQ: VTRS), a global healthcare company, to develop novel engineered bacteriophage products targeting ophthalmic bacterial infections.Under the terms of the agreement, Locus and Viatris will collaborate to develop precision antibacterial therapeutics for serious eye infections, an area of high unmet medical need due to the rise in antibiotic-resistant infections worldwide.Locus’s proprietary development platform integrates predictive artificial intelligence (AI), high-throughput robotics, and synthetic biology to create bacteriophage cocktails that selectively elimi
Show less
Read more
Impact Snapshot
Event Time:
VTRS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTRS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTRS alerts
High impacting Viatris Inc. news events
Weekly update
A roundup of the hottest topics
VTRS
News
- Viatris Inc. (VTRS) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- What Do Recent Portfolio Streamlining Moves Mean for Viatris's True Value in 2025? [Yahoo! Finance]Yahoo! Finance
- Viatris to Participate in Upcoming Investor ConferencesPR Newswire
- Looking at the Changing Narrative for Idorsia After Recent Analyst and Market Developments [Yahoo! Finance]Yahoo! Finance
- European study shows falling prices, rising costs and shortages - findings from independent study presented during World AMR Awareness Week by Viatris and Medicines for EuropePR Newswire
VTRS
Earnings
- 11/6/25 - Beat
VTRS
Sec Filings
- 12/5/25 - Form 8-K
- 12/5/25 - Form 8-K/A
- 11/10/25 - Form SCHEDULE
- VTRS's page on the SEC website